FDA Drug/Biologics Approval BLA 103976 S-5231, OMALIZUMAB

FDA Drug/Biologics Approval BLA 103976 S-5231, OMALIZUMAB

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
BLA 103976 S-5231
Company: GENENTECH
Drug Name: XOLAIR
Active Ingredients: OMALIZUMAB
Strength: 300MG/2ML
Dosage Form/Route: SYRINGE
Action Date: 06/20/2003
Marketing Status: Prescription
Submission Classification: ORIG-1
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details